Cargando…

Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective

BACKGROUND: The General Data Protection Regulation is a regulation in EU law on data protection and privacy in the European Union. We aimed to provide an overview of the General Data Protection Regulation (GDPR) enablers and barriers to the secondary use of health data in Europe from the research we...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukovic, Jakov, Ivankovic, Damir, Habl, Claudia, Dimnjakovic, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994086/
https://www.ncbi.nlm.nih.gov/pubmed/35397557
http://dx.doi.org/10.1186/s13690-022-00866-7
_version_ 1784684035985899520
author Vukovic, Jakov
Ivankovic, Damir
Habl, Claudia
Dimnjakovic, Jelena
author_facet Vukovic, Jakov
Ivankovic, Damir
Habl, Claudia
Dimnjakovic, Jelena
author_sort Vukovic, Jakov
collection PubMed
description BACKGROUND: The General Data Protection Regulation is a regulation in EU law on data protection and privacy in the European Union. We aimed to provide an overview of the General Data Protection Regulation (GDPR) enablers and barriers to the secondary use of health data in Europe from the research we conducted in the Joint Action InfAct (Information for Action!) WP10 Assessing and piloting interoperability for public health policy, as well as to provide an example of a national-level case study on experiences with secondary use of health data and GDPR on an example of the Austrian COVID-19 data platform. METHODS: We have identified a number of European initiatives, projects and organizations that have dealt with cross-border health data sharing, linkage and management by desk research and we conducted 17 semi-structured in-depth interviews and analyzed the interview transcripts by framework analysis. RESULTS: GDPR was seen as an enabler to the secondary use of health data in Europe when it comes to user rights over their data, pre-existing laws regarding data privacy and data sharing, sharing anonymized statistics, developing new data analysis approaches, patients` trust towards dealing with their health data and transparency. GDPR was seen as a barrier to the secondary use of health data in Europe when it comes to identifiable and individual-level data, data sharing, time needed to complete the process, workload increase, differences with local legal legislations, different (and stricter) interpretations and access to data. CONCLUSION: The results of our analysis show that GDPR acts as both an enabler and a barrier for the secondary use of health data in Europe. More research is needed to better understand the effects of GDPR on the secondary use of health data which can serve as a basis for future changes in the regulation.
format Online
Article
Text
id pubmed-8994086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89940862022-04-10 Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective Vukovic, Jakov Ivankovic, Damir Habl, Claudia Dimnjakovic, Jelena Arch Public Health Research BACKGROUND: The General Data Protection Regulation is a regulation in EU law on data protection and privacy in the European Union. We aimed to provide an overview of the General Data Protection Regulation (GDPR) enablers and barriers to the secondary use of health data in Europe from the research we conducted in the Joint Action InfAct (Information for Action!) WP10 Assessing and piloting interoperability for public health policy, as well as to provide an example of a national-level case study on experiences with secondary use of health data and GDPR on an example of the Austrian COVID-19 data platform. METHODS: We have identified a number of European initiatives, projects and organizations that have dealt with cross-border health data sharing, linkage and management by desk research and we conducted 17 semi-structured in-depth interviews and analyzed the interview transcripts by framework analysis. RESULTS: GDPR was seen as an enabler to the secondary use of health data in Europe when it comes to user rights over their data, pre-existing laws regarding data privacy and data sharing, sharing anonymized statistics, developing new data analysis approaches, patients` trust towards dealing with their health data and transparency. GDPR was seen as a barrier to the secondary use of health data in Europe when it comes to identifiable and individual-level data, data sharing, time needed to complete the process, workload increase, differences with local legal legislations, different (and stricter) interpretations and access to data. CONCLUSION: The results of our analysis show that GDPR acts as both an enabler and a barrier for the secondary use of health data in Europe. More research is needed to better understand the effects of GDPR on the secondary use of health data which can serve as a basis for future changes in the regulation. BioMed Central 2022-04-09 /pmc/articles/PMC8994086/ /pubmed/35397557 http://dx.doi.org/10.1186/s13690-022-00866-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vukovic, Jakov
Ivankovic, Damir
Habl, Claudia
Dimnjakovic, Jelena
Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title_full Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title_fullStr Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title_full_unstemmed Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title_short Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective
title_sort enablers and barriers to the secondary use of health data in europe: general data protection regulation perspective
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994086/
https://www.ncbi.nlm.nih.gov/pubmed/35397557
http://dx.doi.org/10.1186/s13690-022-00866-7
work_keys_str_mv AT vukovicjakov enablersandbarrierstothesecondaryuseofhealthdataineuropegeneraldataprotectionregulationperspective
AT ivankovicdamir enablersandbarrierstothesecondaryuseofhealthdataineuropegeneraldataprotectionregulationperspective
AT hablclaudia enablersandbarrierstothesecondaryuseofhealthdataineuropegeneraldataprotectionregulationperspective
AT dimnjakovicjelena enablersandbarrierstothesecondaryuseofhealthdataineuropegeneraldataprotectionregulationperspective